Teladoc Q4 results beat on both lines; 2026 guidance figures include consensus
2026-02-25 16:56:26 ET
More on Teladoc Health
- Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade)
- Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Teladoc Health GAAP EPS of -$0.14 beats by $0.04, revenue of $642.27M beats by $6.94M
- Teladoc Health Q4 Preview: Here's what to expect
Read the full article on Seeking Alpha
For further details see:
Teladoc Q4 results beat on both lines; 2026 guidance figures include consensusNASDAQ: TDOC
TDOC Trading
9.02% G/L:
$5.62 Last:
8,336,469 Volume:
$6.01 Open:



